Takagi T - Search Results

1

Optimization of first-line systemic therapy in patients with advanced clear cell renal cell carcinoma.

Takagi T. Takagi T. Int J Urol. 2023 Sep;30(9):705-713. doi: 10.1111/iju.15103. Epub 2022 Dec 7. Int J Urol. 2023. PMID: 36479730 Review.

2

Clinical results and pharmacokinetics of sorafenib in chronic hemodialysis patients with metastatic renal cell carcinoma in a single center.

Kennoki T, Kondo T, Kimata N, Murakami J, Ishimori I, Nakazawa H, Hashimoto Y, Kobayashi H, Iizuka J, Takagi T, Yoshida K, Tanabe K. Kennoki T, et al. Among authors: takagi t. Jpn J Clin Oncol. 2011 May;41(5):647-55. doi: 10.1093/jjco/hyr015. Epub 2011 Mar 2. Jpn J Clin Oncol. 2011. PMID: 21367805

3

Postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy.

Takagi T, Kondo T, Iizuka J, Kobayashi H, Hashimoto Y, Nakazawa H, Ito F, Tanabe K. Takagi T, et al. Int J Urol. 2011 Jun;18(6):472-6. doi: 10.1111/j.1442-2042.2011.02765.x. Epub 2011 Apr 11. Int J Urol. 2011. PMID: 21481013

4

Decompressive surgery in combination with preoperative transcatheter arterial embolization: successful improvement of ambulatory function in renal cell carcinoma patients with metastatic extradural spinal cord compression.

Suzuki H, Kondo T, Kuwatsuru R, Wada K, Kubota M, Kobayashi H, Iizuka J, Ikezawa E, Takagi T, Tanabe K. Suzuki H, et al. Among authors: takagi t. Int J Urol. 2011 Oct;18(10):718-22. doi: 10.1111/j.1442-2042.2011.02822.x. Epub 2011 Aug 4. Int J Urol. 2011. PMID: 21815936

5

Prognosis and characteristics of renal cell carcinoma in hemodialysis patients: bilateral occurrence does not influence cancer-specific survival.

Takagi T, Kondo T, Izuka J, Kobayashi H, Tomita E, Hashimoto Y, Tanabe K. Takagi T, et al. Int J Urol. 2011 Dec;18(12):806-12. doi: 10.1111/j.1442-2042.2011.02852.x. Epub 2011 Sep 14. Int J Urol. 2011. PMID: 21917022

6

Predictors for postoperative renal function after open partial nephrectomy: including postoperative biomarkers.

Takagi T, Kondo T, Iizuka J, Tomita E, Kobayashi H, Hashimoto Y, Tanabe K. Takagi T, et al. Int J Urol. 2012 Sep;19(9):823-8. doi: 10.1111/j.1442-2042.2012.03037.x. Epub 2012 May 8. Int J Urol. 2012. PMID: 22568789

7

Cytoreductive nephrectomy for pT3b-T4 M1 renal cell carcinoma in 39 patients: single center analysis.

Takagi T, Kondo T, Iizuka J, Kobayashi H, Hashimoto Y, Tanabe K. Takagi T, et al. Int J Urol. 2012 Sep;19(9):875-9. doi: 10.1111/j.1442-2042.2012.03038.x. Epub 2012 May 8. Int J Urol. 2012. PMID: 22568824

8

Similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma.

Iizuka J, Kondo T, Hashimoto Y, Kobayashi H, Ikezawa E, Takagi T, Omae K, Tanabe K. Iizuka J, et al. Among authors: takagi t. Int J Urol. 2012 Nov;19(11):980-6. doi: 10.1111/j.1442-2042.2012.03085.x. Epub 2012 Jun 26. Int J Urol. 2012. PMID: 22735049

9

Comparison of survival rates in patients with metastatic renal cell carcinoma according to treatment era including cytokine and targeted therapy.

Takagi T, Kondo T, Kennoki T, Iizuka J, Kobayashi H, Hashimoto Y, Tanabe K. Takagi T, et al. Jpn J Clin Oncol. 2013 Apr;43(4):439-43. doi: 10.1093/jjco/hys234. Epub 2013 Jan 9. Jpn J Clin Oncol. 2013. PMID: 23303839

10

Negative impact of papillary histological subtype in patients with renal cell carcinoma extending into the inferior vena cava: single-center experience.

Kondo T, Ikezawa E, Takagi T, Kobayashi H, Hashimoto Y, Iizuka J, Omae K, Yoshida K, Tanabe K. Kondo T, et al. Among authors: takagi t. Int J Urol. 2013 Nov;20(11):1072-7. doi: 10.1111/iju.12123. Epub 2013 Feb 20. Int J Urol. 2013. PMID: 23421632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,036 results

Search Page